Duško Đunđerović

957 total citations
12 papers, 114 citations indexed

About

Duško Đunđerović is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Duško Đunđerović has authored 12 papers receiving a total of 114 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Duško Đunđerović's work include Thyroid Cancer Diagnosis and Treatment (3 papers), Protease and Inhibitor Mechanisms (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). Duško Đunđerović is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (3 papers), Protease and Inhibitor Mechanisms (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). Duško Đunđerović collaborates with scholars based in Serbia, Italy and Germany. Duško Đunđerović's co-authors include Sanja Mijatović, Danijela Maksimović‐Ivanić, Goran N. Kaluđerović, Biljana Dojčinović, Santa Mammana, Svetlana Paskaš, Svetlana Savin, Andjelija Ž. Ilić, Yousef Al‐Abed and Milan Gajić and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Food and Chemical Toxicology.

In The Last Decade

Duško Đunđerović

11 papers receiving 113 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Duško Đunđerović Serbia 8 45 30 14 13 13 12 114
Ezgi Kaya-Aksoy Türkiye 6 99 2.2× 26 0.9× 25 1.8× 20 1.5× 10 0.8× 8 159
Szabolcs Tarapcsák Hungary 8 90 2.0× 74 2.5× 14 1.0× 8 0.6× 10 0.8× 12 162
Inês Silva Portugal 8 79 1.8× 23 0.8× 11 0.8× 7 0.5× 16 1.2× 16 193
Raed Alserihi Saudi Arabia 9 88 2.0× 21 0.7× 26 1.9× 26 2.0× 9 0.7× 22 246
Donghui Sun China 4 83 1.8× 19 0.6× 20 1.4× 9 0.7× 4 0.3× 7 142
Yonghui Mao China 8 94 2.1× 19 0.6× 19 1.4× 14 1.1× 6 0.5× 21 229
Francesco Ragonese Italy 10 98 2.2× 13 0.4× 23 1.6× 19 1.5× 31 2.4× 22 249
Shah Zeb Khan Italy 6 89 2.0× 55 1.8× 17 1.2× 8 0.6× 7 0.5× 15 220
Karolina Siewiera Poland 11 79 1.8× 36 1.2× 13 0.9× 14 1.1× 6 0.5× 24 217
C. Blasco Spain 4 101 2.2× 49 1.6× 40 2.9× 24 1.8× 12 0.9× 9 222

Countries citing papers authored by Duško Đunđerović

Since Specialization
Citations

This map shows the geographic impact of Duško Đunđerović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duško Đunđerović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duško Đunđerović more than expected).

Fields of papers citing papers by Duško Đunđerović

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duško Đunđerović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duško Đunđerović. The network helps show where Duško Đunđerović may publish in the future.

Co-authorship network of co-authors of Duško Đunđerović

This figure shows the co-authorship network connecting the top 25 collaborators of Duško Đunđerović. A scholar is included among the top collaborators of Duško Đunđerović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duško Đunđerović. Duško Đunđerović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Biancalana, Lorenzo, Biljana Dojčinović, Duško Đunđerović, et al.. (2024). FETPY: a Diiron(I) Thio–Carbyne Complex with Prominent Anticancer Activity In Vitro and In Vivo. Journal of Medicinal Chemistry. 67(9). 7553–7568. 9 indexed citations
2.
Jovanović, Ivan, Nevena Gajović, Duško Đunđerović, et al.. (2024). Antimelanoma Effects of Alchemilla vulgaris: A Comprehensive In Vitro and In Vivo Study. SHILAP Revista de lepidopterología. 12(6). 125–125. 1 indexed citations
3.
Jovanović, Milan, Duško Đunđerović, Nikola Slijepčević, et al.. (2023). Case presentation of the smallest non-functional parathyroid carcinoma and review of the literature. European Archives of Oto-Rhino-Laryngology. 280(12). 5637–5647. 2 indexed citations
4.
Đunđerović, Duško, Svetislav Tatić, Sanja Radojević-Škodrić, et al.. (2022). Matrix Metalloproteinases 2 and 9 and Their Tissue Inhibitors in the Diagnostics of Medullary Thyroid Carcinoma. Applied immunohistochemistry & molecular morphology. 31(2). 121–127.
5.
Dojčinović, Biljana, et al.. (2021). Antitumor potential of cisplatin loaded into SBA-15 mesoporous silica nanoparticles against B16F1 melanoma cells: in vitro and in vivo studies. Journal of Inorganic Biochemistry. 217. 111383–111383. 18 indexed citations
6.
Kovačević, Sanjin, et al.. (2021). Effects of Automation on Sustainability of Immunohistochemistry Laboratory. Healthcare. 9(7). 866–866. 2 indexed citations
7.
Kovačević, Sanjin, et al.. (2020). The Fractal and GLCM Textural Parameters of Chromatin May Be Potential Biomarkers of Papillary Thyroid Carcinoma in Hashimoto's Thyroiditis Specimens. Microscopy and Microanalysis. 26(4). 717–730. 17 indexed citations
8.
Kaluđerović, Goran N., Duško Đunđerović, Ivana Mirkov, et al.. (2019). The hop-derived prenylflavonoid isoxanthohumol inhibits the formation of lung metastasis in B16-F10 murine melanoma model. Food and Chemical Toxicology. 129. 257–268. 19 indexed citations
9.
Đunđerović, Duško, et al.. (2019). PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance. Diagnostic Pathology. 14(1). 120–120. 9 indexed citations
10.
Đunđerović, Duško, et al.. (2019). Primary leiomyosarcoma of the thyroid gland with prior malignancy and radiotherapy: A case report and review of literature. World Journal of Clinical Cases. 7(4). 473–481. 7 indexed citations
11.
Paskaš, Svetlana, Maria Sofia Basile, Duško Đunđerović, et al.. (2019). Senescence as a main mechanism of Ritonavir and Ritonavir‐NO action against melanoma. Molecular Carcinogenesis. 58(8). 1362–1375. 18 indexed citations
12.
Dragutinović, Vesna, Svetislav Tatić, Snežana Nikolić-Mandić, et al.. (2012). Matrix Metalloproteinase-9 and the Cu/Zn Ratio as Ancillary Diagnostic Tools in Distinguishing Between the Classical and Follicular Variants of Papillary Thyroid Carcinoma. Biological Trace Element Research. 149(1). 29–33. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026